This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Extracellular Vesicles in Diagnostics and Therapeutics

Extracellular Vesicles in Diagnostics and Therapeutics

Tuesday, February 19, 2019, 9:00 AM - 6:00 PM

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

The Biochemical Pharmacology Discussion Group

The New York Academy of Sciences

 

The field of extracellular vesicles (EV) research has expanded dramatically in recent years, providing new insights into their critical biological functions as well as their therapeutic and diagnostic applications. A heterogeneous pool of lipid-enclosed vesicles, EVs are associated with a wide variety of cell types and encapsulate molecular cargoes such as miRNAs, mRNAs, proteins and lipids. Once thought of simply as carriers of metabolic waste, we now know that these vesicles perform a wide range of tissue-specific functions and are important for cell-cell communication.

The relative simplicity of EV isolation techniques from non-invasive biofluid sampling, in addition to the wealth of information contained therein, makes EV a promising tool for diagnostics and biomarker discovery. Furthermore, EVs are gaining traction as therapeutics themselves, as a unique drug delivery system for a potentially wide variety of indications.

In this symposium, we will review the most recent advances in EV research and their increasing impact on diagnostics and drug development for cancer, neurodegenerative disease, metabolic disease, and cardiovascular disease.

Call for Abstracts

Abstract submissions are invited for a poster session. For complete submission instructions, please visit our online portal. The deadline for abstract submission is Tuesday, December 11, 2018.

Registration

Member
By 01/08/2019
$90
After 01/08/2019
$130
Nonmember Academia, Faculty, etc.
By 01/08/2019
$180
After 01/08/2019
$260
Nonmember Corporate, Other
By 01/08/2019
$250
After 01/08/2019
$350
Nonmember Not for Profit
By 01/08/2019
$180
After 01/08/2019
$260
Nonmember Student, Undergrad, Grad, Fellow
By 01/08/2019
$100
After 01/08/2019
$145
Member Student, Post-Doc, Fellow
By 01/08/2019
$50
After 01/08/2019
$70
Deadline:
54
days
left

Keynote Speaker

Xandra Breakefield, PhD,
Harvard University

Speakers

Elena V. Batrakova, PhD, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
Richard A. Cerione, PhD, Cornell University
David C. Lyden, MD, PhD, Weill Cornell Medical College
Harmeet Malhi, MBBS, Mayo Clinic
Susmita Sahoo, PhD, Icahn School of Medicine at Mount Sinai
Johan Skog, PhD, Exosome Diagnostics Inc
Alissa Weaver, PhD, Vanderbilt University School of Medicine

Scientific Organizing Committee

Richard A. Cerione, PhD,
Cornell University
Jemy A. Gutierrez, PhD,
Pfizer
Jorge Schettini, PhD,
Pfizer
Claire Steppan, PhD,
Pfizer
Gregory Tesz, PhD,
Pfizer
Theresa Wilson, PhD,
Pfizer
Alissa Weaver, PhD,
Vanderbilt University School of Medicine
Sonya Dougal, PhD,
The New York Academy of Sciences
Alison Carley, PhD,
The New York Academy of Sciences